Patents by Inventor Mark George

Mark George has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12362094
    Abstract: The subject matter described herein relates to laminated magnetic cores, methods of fabricating laminated magnetic cores, and electric devices using laminated magnetic cores. In some examples, a method for fabricating a laminated magnetic core includes depositing a first magnetic layer and depositing an interlamination layer of over the first magnetic layer. The interlamination layer comprises a partially conducting material having a conductivity greater than or equal to 10?4 S/cm and less than or equal to 105 S/cm. The method includes depositing a second magnetic layer over the interlamination layer. The method can include sequentially depositing additional interlamination layers and additional magnetic layers in an alternating fashion to produce the laminated magnetic core.
    Type: Grant
    Filed: May 21, 2024
    Date of Patent: July 15, 2025
    Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventors: Mark George Allen, Min Soo Kim
  • Publication number: 20250223280
    Abstract: Extracellular protein degraders and compositions are provided that have a potent asialoglycoprotein receptor (ASGPR) Binding Ligand bound to an Extracellular Protein Targeting Ligand for the selective degradation of the Target Extracellular Protein, for example immunoglobulin in vivo to treat disorders mediated by the extracellular protein.
    Type: Application
    Filed: March 17, 2025
    Publication date: July 10, 2025
    Applicant: AVILAR THERAPEUTICS, INC.
    Inventors: Jason Allan Wiles, Srinivasa Karra, Mark George Saulnier, Jesse Jingyang Chen, Kevin Tyler Sprott, Soumya Ray
  • Publication number: 20250213699
    Abstract: Compounds and compositions that have an asialoglycoprotein receptor (ASGPR) binding ligand bound to an extracellular protein binding ligand for the selective degradation of the target extracellular protein in vivo to treat disorders mediated by the extracellular protein are described.
    Type: Application
    Filed: March 17, 2025
    Publication date: July 3, 2025
    Applicant: AVILAR THERAPEUTICS, INC.
    Inventors: Mark George Saulnier, Jesse Jingyang Chen, Srinivasa Karra, Kevin Tyler Sprott, Jason Allan Wiles, Soumya Ray
  • Patent number: 12337166
    Abstract: The present invention relates to systems for providing noninvasive cranial nerve stimulation and methods for using the same. The present invention administers therapy through electrodes that are noninvasively attached to one or more of a subject's cranial nerve. The systems can be used to enhancing rehabilitation and recovery by improving neuroplasticity and coupling muscle training with feedback.
    Type: Grant
    Filed: November 29, 2022
    Date of Patent: June 24, 2025
    Assignee: MUSC Foundation for Research Development
    Inventors: Bashar Badran, Mark George, Doe Jenkins, Daniel Cook
  • Patent number: 12334239
    Abstract: In some examples, a patterned magnetic core includes a first sub-score and at least one second sub-core. The first and second sub-cores are spaced apart by a gap, optionally filled with material of sufficiently low electrical conductivity. Each of the first and second sub-scores includes a number of magnetic layers and a number of interlamination layers disposed between the magnetic layers in an alternating fashion.
    Type: Grant
    Filed: October 28, 2019
    Date of Patent: June 17, 2025
    Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventors: Mark George Allen, Min Soo Kim
  • Publication number: 20250171465
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: June 24, 2024
    Publication date: May 29, 2025
    Inventors: Eddine Saiah, Tyler Mann, Jorden Kass, Louise Clare Kirman, Mark George Saulnier, Lisa A. De Meese, Richard James Steel, Kap-Sun Yeung
  • Patent number: 12312340
    Abstract: Extracellular protein degraders and compositions are provided that have a potent asialoglycoprotein receptor (ASGPR) Binding Ligand bound to an Extracellular Protein Targeting Ligand for the selective degradation of the Target Extracellular Protein, for example immunoglobulin in vivo to treat disorders mediated by the extracellular protein.
    Type: Grant
    Filed: February 28, 2024
    Date of Patent: May 27, 2025
    Assignee: Avilar Therapeutics, Inc.
    Inventors: Jason Allan Wiles, Srinivasa Karra, Mark George Saulnier, Jesse Jingyang Chen, Kevin Tyler Sprott, Soumya Ray
  • Patent number: 12290568
    Abstract: Compounds and compositions that have an asialoglycoprotein receptor (ASGPR) binding ligand bound to an extracellular protein binding ligand for the selective degradation of the target extracellular protein in vivo to treat disorders mediated by the extracellular protein are described.
    Type: Grant
    Filed: May 2, 2024
    Date of Patent: May 6, 2025
    Assignee: AVILAR THERAPEUTICS, INC.
    Inventors: Mark George Saulnier, Jesse Jingyang Chen, Srinivasa Karra, Kevin Tyler Sprott, Jason Allan Wiles, Soumya Ray
  • Publication number: 20250127907
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: June 24, 2024
    Publication date: April 24, 2025
    Inventors: Eddine Saiah, Tyler Mann, Jorden Kass, Louise Clare Kirman, Mark George Saulnier, Lisa A. De Meese, Richard James Steel, Kap-Sun Yeung
  • Patent number: 12280116
    Abstract: Compounds and compositions that have an asialoglycoprotein receptor (ASGPR) binding ligand bound to an extracellular protein binding ligand for the selective degradation of the target extracellular protein in vivo to treat disorders mediated by the extracellular protein are described.
    Type: Grant
    Filed: May 2, 2024
    Date of Patent: April 22, 2025
    Assignee: AVILAR THERAPEUTICS, INC.
    Inventors: Mark George Saulnier, Jesse Jingyang Chen, Srinivasa Karra, Kevin Tyler Sprott, Jason Allan Wiles, Soumya Ray
  • Patent number: 12275219
    Abstract: Disclosed herein are compositions including a thermoformable sheet having three of more layers. Two layers include one or more monovinylidene aromatic monomer containing polymers which are impact modified by a rubber, one or more monovinylidene aromatic monomer and unsaturated nitrile containing copolymers, or a blend of one or more monovinylidene aromatic monomer containing polymers and a polyolefin, which exhibit resistance to environmental stress cracking. At least one of the two layers is an outer layer. An inner layer includes post-consumer recycled monovinylidene aromatic monomer containing polymers which are impact modified by a rubber, post-industrial recycled monovinylidene aromatic monomer containing polymers which are impact modified by a rubber. Optionally, the composition may include virgin monovinylidene aromatic monomer containing polymers which are impact modified by a rubber. Optionally, the composition may include an outer layer which is a gloss layer.
    Type: Grant
    Filed: September 14, 2022
    Date of Patent: April 15, 2025
    Assignee: TRINSEO EUROPE GMBH
    Inventors: Mark Georges Vreys, Claude T. E. Van Nuffel, Abidin Balan
  • Publication number: 20250041866
    Abstract: A sensor for detecting a target analyte in a sample includes a pair of conducting electrodes that are separated by a gap. An insulator is disposed in the gap between the electrodes. Plural wells are defined by one of the electrodes and the insulator, to expose the other of the electrodes. The wells are configured to receive a sample including a target analyte. The target analyte, when present in the sample received in the wells, modulates an impedance between the electrodes. The modulated impedance, which is measurable with an applied electrical voltage, is indicative of the concentration of the target analyte in the sample. The wells can include antibodies immobilized inside the wells, to bind the target analyte, which can be a cytokine. Also provided are a method for label-free sensing of a target analyte in a sample, and a transcutaneous impedance sensor for label-free, in-situ biomarker detection.
    Type: Application
    Filed: August 21, 2024
    Publication date: February 6, 2025
    Inventors: Pengfei Xie, Mehdi Javanmard, Mark George Allen, Wen Shen, Naixin Song
  • Patent number: 12191128
    Abstract: An apparatus for sputtering target material onto a substrate based on a plasma confining racetrack having two parallel straight portions and two turnaround portions includes a tubular target, an elongated magnet array, and a drive mechanism. The tubular target has two ends in proximity to the two turnaround portions and a longitudinal axis about which the target is rotatable. The magnet array is supported within the target to generate a plasma-confining magnetic field. The array includes a central stationary portion of magnets and two axially movable shunts positioned at the ends of the stationary portion. Each shunt carries a magnet segment configured to slidably extend from each end of the stationary portion to define a gap. The gaps are positioned internal to the turnaround portions. The drive mechanism axially moves the shunts parallel to the longitudinal axis of the target to vary a width of the gaps.
    Type: Grant
    Filed: March 11, 2021
    Date of Patent: January 7, 2025
    Assignee: Intellivation LLC
    Inventors: Michael G. Simmons, Joshua D. Misek, Mark George
  • Publication number: 20240424108
    Abstract: Compounds and compositions that have an asialoglycoprotein receptor (ASGPR) binding ligand bound to an extracellular protein binding ligand for the selective degradation of the target extracellular protein in vivo to treat disorders mediated by the extracellular protein are described.
    Type: Application
    Filed: May 2, 2024
    Publication date: December 26, 2024
    Applicant: AVILAR THERAPEUTICS, INC.
    Inventors: Mark George Saulnier, Jesse Jingyang Chen, Srinivasa Karra, Kevin Tyler Sprott, Jason Allan Wiles, Soumya Ray
  • Patent number: 12173097
    Abstract: A composition includes one or more copolymers of one or more vinylidene aromatic monomers and one or more unsaturated compounds containing nucleophilic groups, and the copolymer has on average about 0.01 to about 15.0 percent by weight of nucleophilic groups pendant from the copolymer. The copolymer is chain extended and/or branched by one or more copolymers of one or more vinylidene aromatic monomers and one or more unsaturated compounds having electrophilic groups, or a portion of the chains of the copolymer of one or more vinylidene aromatic monomers and one or more nucleophilic groups are crosslinked with other chains of the copolymer of one or more vinylidene aromatic monomers and one or more nucleophilic groups by ionic bonding of anions formed from the pendant nucleophilic groups with a metal cation having a valence of 2 or greater or complexation between pendant acid groups and metal oxides.
    Type: Grant
    Filed: September 14, 2022
    Date of Patent: December 24, 2024
    Assignee: TRINSEO EUROPE GMBH
    Inventors: Mark Georges Vreys, Claude T. E. Van Nuffel, Abidin Balan
  • Publication number: 20240358842
    Abstract: This invention provides protein stabilizing compounds, compositions, and methods of use thereof, that include a USP7 Targeting Ligand, a Protein Targeting Ligand, and optionally a Linker for the restoration of a Target Ubiquitinated Protein to treat a disorder mediated by deficiencies of the Target Protein.
    Type: Application
    Filed: June 24, 2022
    Publication date: October 31, 2024
    Inventors: Kevin Tyler SPROTT, Mark George SAULNIER, Moses MOUSTAKIM, Brian BOWMAN, Jorden KASS, Richard James STEEL
  • Patent number: 12128106
    Abstract: Compounds and compositions that have an asialoglycoprotein receptor (ASGPR) binding ligand bound to an extracellular protein binding ligand for the selective degradation of the target extracellular protein in vivo to treat disorders mediated by the extracellular protein are described.
    Type: Grant
    Filed: February 22, 2024
    Date of Patent: October 29, 2024
    Assignee: Avilar Therapeutics, Inc.
    Inventors: Mark George Saulnier, Jesse Jingyang Chen, Srinivasa Karra, Kevin Tyler Sprott, Jason Allan Wiles, Soumya Ray
  • Patent number: 12122206
    Abstract: Example illustrations are directed to a suspension system for a vehicle and methods. In some examples, a controller of a suspension system is configured to determine the vehicle is in a service environment, and to set a height precision mode for the suspension system based on the determination the vehicle is in the service environment. In some examples, the controller is configured to detect a suspension operating condition of the vehicle, and to change a setting associated with the suspension system based on the suspension operating condition. An example method comprises detecting, using a controller, a suspension operating condition of a suspension system of a vehicle. The method may further include changing, using the controller, a setting associated with the suspension system based upon the suspension operating condition.
    Type: Grant
    Filed: July 11, 2022
    Date of Patent: October 22, 2024
    Assignee: RIVIAN IP HOLDINGS, LLC
    Inventors: Thomas Frederick Abdallah, Mark George Milne, Jay Dixit, Derrick Michael Tan
  • Publication number: 20240327555
    Abstract: A composition includes one or more copolymers of one or more vinylidene aromatic monomers and one or more unsaturated compounds containing nucleophilic groups, and the copolymer has on average about 0.01 to about 15.0 percent by weight of nucleophilic groups pendant from the copolymer. The copolymer is chain extended and/or branched by one or more copolymers of one or more vinylidene aromatic monomers and one or more unsaturated compounds having electrophilic groups, or a portion of the chains of the copolymer of one or more vinylidene aromatic monomers and one or more nucleophilic groups are crosslinked with other chains of the copolymer of one or more vinylidene aromatic monomers and one or more nucleophilic groups by ionic bonding of anions formed from the pendant nucleophilic groups with a metal cation having a valence of 2 or greater or complexation between pendant acid groups and metal oxides.
    Type: Application
    Filed: September 14, 2022
    Publication date: October 3, 2024
    Inventors: Mark Georges Vreys, Claude T.E. Van Nuffel, Abidin Balan
  • Patent number: 12097500
    Abstract: A sensor for detecting a target analyte in a sample includes a pair of conducting electrodes that are separated by a gap. An insulator is disposed in the gap between the electrodes. Plural wells are defined by one of the electrodes and the insulator, to expose the other of the electrodes. The wells are configured to receive a sample including a target analyte. The target analyte, when present in the sample received in the wells, modulates an impedance between the electrodes. The modulated impedance, which is measurable with an applied electrical voltage, is indicative of the concentration of the target analyte in the sample. The wells can include antibodies immobilized inside the wells, to bind the target analyte, which can be a cytokine. Also provided are a method for label-free sensing of a target analyte in a sample, and a transcutaneous impedance sensor for label-free, in-situ biomarker detection.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: September 24, 2024
    Assignees: Rutgers, The State University of New Jersey, The Trustees of the University of Pennsylvania
    Inventors: Pengfei Xie, Mehdi Javanmard, Mark George Allen, Wen Shen, Naixin Song